Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 279109, 12 pages
http://dx.doi.org/10.1155/2015/279109
Research Article

Genetic Variations in ABCG2 Gene Predict Breast Carcinoma Susceptibility and Clinical Outcomes after Treatment with Anthracycline-Based Chemotherapy

1Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110122, China
2Department of Clinical Laboratory, Shengjing Hospital of China Medical University, Heping Ward, Shenyang, Liaoning 110003, China
3Department of Clinical Laboratory, The First Hospital of China Medical University, Heping Ward, Shenyang, Liaoning 110001, China
4Institute of Pathology and Pathophysiology, The First Hospital and College of Basic Medical Sciences of China Medical University, Heping Ward, Shenyang, Liaoning 110001, China

Received 8 June 2015; Revised 13 September 2015; Accepted 12 October 2015

Academic Editor: Siddharth Pratap

Copyright © 2015 Huizhe Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Huizhe Wu, Yong Liu, Hui Kang, et al., “Genetic Variations in ABCG2 Gene Predict Breast Carcinoma Susceptibility and Clinical Outcomes after Treatment with Anthracycline-Based Chemotherapy,” BioMed Research International, vol. 2015, Article ID 279109, 12 pages, 2015. doi:10.1155/2015/279109